Citation sources

Updated weekly. Details via Crossref
Crossref Scopus Google Scholar
8 10 Search
2025
Efficacy and safety of guselkumab in patients with active lupus nephritis: results from a phase 2, randomized, placebo-controlled study
Rheumatology
2024
Candesartan upregulates angiotensin‐converting enzyme 2 in kidneys of male animals by decreased ubiquitination
The FASEB Journal
2023
Consensus Statements from the Diabetologists & Endocrinologists Alliance for the Management of People with Hypertension and Type 2 Diabetes Mellitus
Journal of Clinical Medicine
2022
Renin-angiotensin system blocker and the COVID-19 aggravation in patients with hypertension, diabetes, renal failure, Cerebro-cardiovascular disease, or pulmonary disease: Report by the COVID-19 Registry Japan
Journal of Cardiology
2022
Pharmacotherapy to delay the progression of diabetic kidney disease in people with type 2 diabetes: past, present and future
Therapeutic Advances in Endocrinology and Metabolism
2021
Efficacy and Safety of Tripterygium Glycoside in the Treatment of Diabetic Nephropathy: A Systematic Review and Meta-Analysis Based on the Duration of Medication
Frontiers in Endocrinology
2021
From Proteinuria to Fibrosis: An Update on Pathophysiology and Treatment Options
Kidney and Blood Pressure Research
2021
Comparative efficacy of different renin angiotensin system blockade therapies in patients with IgA nephropathy: a Bayesian network meta-analysis of 17 RCTs
PeerJ
Additional cited-by details will be shown when available from Crossref